Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study
- Orkin, C.
- Bernal Morell, E.
- Tan, D.H.S.
- Katner, H.
- Stellbrink, H.-J.
- Belonosova, E.
- DeMoor, R.
- Griffith, S.
- Thiagarajah, S.
- Van Solingen-Ristea, R.
- Ford, S.L.
- Crauwels, H.
- Patel, P.
- Cutrell, A.
- Smith, K.Y.
- Vandermeulen, K.
- Birmingham, E.
- St Clair, M.
- Spreen, W.R.
- D'Amico, R.
ISSN: 2352-3018
Année de publication: 2021
Volumen: 8
Número: 11
Pages: e668-e678
Type: Article